麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Florida鈥檚 KidCare
  • LGBTQ+ Youth Crisis Line
  • Device Coverage by Medicare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Florida鈥檚 KidCare
  • LGBTQ+ Youth Crisis Line
  • Device Coverage by Medicare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, May 1 2024

Full Issue

Perspectives: Inflation Reduction Act Will Make Meds More Affordable; Opill Will Need Teens To Be Educated

Read recent commentaries about pharmaceutical issues.

Thanks to the Inflation Reduction Act, one of President Biden鈥檚 signature achievements, prescription drugs are set to become substantially more affordable for seniors. Yet many Americans seem unaware of just how monumental these changes will be. (Leana S. Wen, 4/30)

Opill was recently recognized as the first FDA-approved over-the-counter daily birth control pill. While this is a step forward for contraceptive access, how can we make sure that young people - who are often navigating their sexual health for the first time and may not be well-informed on safe sex practices - know about the pill and how to obtain it? (Suhanee Mitragotri, 5/1)

Subcutaneous administration of the monoclonal antibody L9LS protected adults against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a monoclonal antibody administered subcutaneously can protect children from P. falciparum infection in a region where this organism is endemic is unclear. (Kassoum Kayentao, M.D., Ph.D., M.P.H., et al, 4/26)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优